When she began working on CRISPR, the University of California, Berkeley's Jennifer Doudna remembers thinking "this is probably the most obscure thing I ever worked on," as she tells the New York Times.

Now because of that obscure work, Doudna and her colleague Emmanuelle Charpentier at Umea University are now embroiled in a patent dispute and an ethical debate.